Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Harmony Biosciences Logo
Harmony Biosciences Growth Score
66
CB Rank
54403
Heat Score
48
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Founded
obfuscation
PublicPost-IPO Secondary Plymouth Meeting, Pennsylvania, United States251-500 www.harmonybiosciences.com
Biopharma
Biotechnology
Health Care
Overview

Harmony Biosciences
Total Funding
obfuscation
Growth Score
66
Heat Score
48

Total Funding
obfuscation
obfuscation
Post-IPO Secondary raised
obfuscation
Growth Score66
-24 pts
in past quarter
Heat Score 48
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Harmony Biosciences

CB Rank
54403
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Founded
obfuscation
PublicPost-IPO Secondary Plymouth Meeting, Pennsylvania, United States251-500 www.harmonybiosciences.com
Biopharma
Biotechnology
Health Care

Funding Rounds

Post-IPO Secondary
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Harmony Biosciences
Operating Status Active
Stock Symbol  NASDAQ:HRMY
Company Type For Profit
Founders  Jeff Aronin
About the Company
Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The company was established in October 2017 with a vision to develop and commercialize innovative therapies for people living with rare neurological disorders who have unmet medical needs.
Phone Number (484) 539-9800
Contact Email info@harmonybiosciences.com
Predictions & Insights

Growth Insight

See this Growth Insight
Harmony Biosciences is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Pitolisant
An H3 receptor antagonist/inverse agonist for treating excessive daytime sleepiness and cataplexy in narcolepsy, also studied for Prader-Willi syndrome and myotonic dystrophy type 1.
BP1.15205 (orexin-2 receptor agonist)
An investigational oral orexin-2 receptor agonist for treating narcolepsy and other sleep/wake disorders.

Research & Development

Harmony Biosciences is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Harmony Biosciences Logo
Post-IPO Secondary - Harmony Biosciences
—
obfuscation
— Post-IPO Secondary

Investors

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 7 Board Members and Advisors 3 Contacts 280

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 8, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

7,408
13.74%
 in past month

IT Spend

$59.6MThis year, Harmony Biosciences is projected to spend $59.6M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Portfolio Analytics Logo
Portfolio Analytics
100
Outcome-Based Selling Logo
Outcome-Based Selling
100
Touch Screen Logo
Touch Screen
98

Actively Used Products

16Harmony Biosciences uses 16 technology products and services including HTML5, DigiCert, and  GlobalSign, according to G2 Stack.

Active Website Tech Count

74Harmony Biosciences is actively using 74 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

1Harmony Biosciences has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Harmony Biosciences's headquarters? Harmony Biosciences is located in Plymouth Meeting, Pennsylvania, United States.Who invested in Harmony Biosciences? Harmony Biosciences has 12 investors including Blackstone Life Sciences and  Blackstone Group.When was the last funding round for Harmony Biosciences? Harmony Biosciences closed its last funding round on
obfuscation
from a Post-IPO Secondary round.Who are Harmony Biosciences's competitors? Alternatives and possible competitors to Harmony Biosciences may include Alto Neuroscience, Zevra Therapeutics, and  MapLight Therapeutics.How much funding has Harmony Biosciences raised to date? Harmony Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|